We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
-2.9%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$13.2B
AUM Growth
-$2.13B
Cap. Flow
+$212M
Cap. Flow %
1.6%
Top 10 Hldgs %
51.27%
Holding
122
New
17
Increased
44
Reduced
28
Closed
23

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$853M
2
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
+$778M
3
AABA
Altaba Inc
AABA
+$385M
4
PPLI
People Inc
PPLI
+$348M
5
BABA icon
Alibaba
BABA
+$288M

Top Sells

Rank Stock Value
1
RHT
Red Hat Inc
RHT
+$964M
2
APC
Anadarko Petroleum
APC
+$738M
3
ARRY
Array Biopharma Inc
ARRY
+$394M
4
BKNG icon
Booking.com
BKNG
+$128M
5
EFX icon
Equifax
EFX
+$117M

Sector Composition

Rank Sector Weight
1 Healthcare 39.58%
2 Technology 13.07%
3 Communication Services 10.54%
4 Industrials 6.1%
5 Consumer Discretionary 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RETA
76
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$14.6M 0.11%
182,060
-617,940
-77% -$52.4M
MLNX
77
DELISTED
Mellanox Technologies, Ltd.
MLNX
$13.7M 0.1%
+125,000
New +$13.8M
CCXI
78
DELISTED
ChemoCentryx, Inc.
CCXI
$13.7M 0.1%
2,013,396
+13,396
+0.7% +$101K
QTNT
79
DELISTED
Quotient Limited Ordinary Shares
QTNT
$13.2M 0.1%
42,500
-20,000
-32% -$7.71M
ACAD icon
80
Acadia Pharmaceuticals
ACAD
$4.9B
$12.6M 0.1%
+350,000
New +$10.6M
EIGR
81
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$11.5M 0.09%
37,500
+4,167
+13% +$1.35M
SVRA icon
82
Savara
SVRA
$1.19B
$9.3M 0.07%
3,510,787
+35,787
+1% +$89.4K
AXSM icon
83
Axsome Therapeutics
AXSM
$10.8B
$8.1M 0.06%
+400,000
New +$10.3M
XGN icon
84
Exagen
XGN
$160M
$5.63M 0.04%
+363,336
New +$5.87M
PFNX
85
DELISTED
Pfenex Inc.
PFNX
$5.06M 0.04%
600,000
– –
CYCN icon
86
Cyclerion Therapeutics
CYCN
$16.7M
$4.57M 0.03%
18,831
-8,373
-31% -$1.81M
QURE icon
87
uniQure
QURE
$3.15B
$3.97M 0.03%
100,922
+922
+0.9% +$53.2K
GCVRZ
88
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.89M 0.03%
6,827,805
– –
DMTK
89
DELISTED
DermTech, Inc. Common Stock
DMTK
$3.45M 0.03%
+615,385
New +$7.34M
PHAS
90
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$3.37M 0.03%
807,928
+50,967
+7% +$406K
APTX
91
DELISTED
Aptinyx Inc. Common Stock
APTX
$2.35M 0.02%
674,141
+4,141
+0.6% +$14.9K
GOSS icon
92
Gossamer Bio
GOSS
$87.2M
$1.69M 0.01%
100,712
+712
+0.7% +$14.2K
COHR icon
93
Coherent
COHR
$65.4B
$1.68M 0.01%
+47,687
New +$1.82M
LRMR icon
94
Larimar Therapeutics
LRMR
$436M
$1.34M 0.01%
150,697
+697
+0.5% +$7.64K
ADPT icon
95
Adaptive Biotechnologies
ADPT
$3.75B
– –
-25,000
Closed -$1.21M
AKRO
96
DELISTED
Akero Therapeutics
AKRO
– –
-150,000
Closed -$2.87M
ASMB icon
97
Assembly Biosciences
ASMB
$524M
– –
-8,333
Closed -$1.35M
CDXS icon
98
Codexis
CDXS
$159M
– –
-1,250,000
Closed -$23M
FOX icon
99
Fox Class B
FOX
$23.2B
– –
-1,182,500
Closed -$43.2M
FOXA icon
100
Fox Class A
FOXA
$25.9B
– –
-836,400
Closed -$30.6M
1 2 3
4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Farallon Capital Management held 122 positions worth $13.2B, down 14% from $15.4B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Farallon Capital Management's Q3 2019 filing shows 17 new, 44 increased, 28 reduced and 23 closed positions. Its largest new stake was Broadmark Realty Capital Inc. Common Stock: 75,000,000 shares worth $77.3M. The largest sale was Red Hat Inc, an estimated $964M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.

  • Farallon Capital Management's largest Q3 2019 buy was Broadmark Realty Capital Inc. Common Stock: 75,000,000 shares worth $77.3M.
  • Farallon Capital Management added most to Allergan plc in Q3 2019, an estimated $853M increase.
  • Farallon Capital Management's biggest Q3 2019 reduction was Booking.com, cutting an estimated $128M.
  • Farallon Capital Management fully exited Red Hat Inc in Q3 2019, selling an estimated $964M.
  • Farallon Capital Management's ten largest holdings make up 51% of its $13.2B portfolio in Q3 2019.
  • Farallon Capital Management opened 17 new positions and closed 23 in Q3 2019.
  • Farallon Capital Management's portfolio value fell 14% quarter-over-quarter to $13.2B.

Based on Farallon Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.